期刊文献+

供体特异性调节性T细胞在肝移植免疫耐受中的意义

Role of donor specific regulatory T cells in immune tolerance after liver transplantation
下载PDF
导出
摘要 免疫耐受是器官移植的终极目标。尽管目前对于移植术后免疫耐受的探索很多,但大多处于试验阶段,应用于临床的方案甚少。对调节性T细胞诱导免疫耐受的研究较为透彻,但供体特异性调节性T细胞因其比例较低、制备困难,在移植免疫中的研究相对较少。本文从调节性T细胞的共性、供体特异性调节性T细胞的抑制功能、体外培养技术、胸腺移植等方面出发,总结供体特异性调节性T细胞在近年的研究热点,以期为临床研究提供新思路。 Immune tolerance is the ultimate goal of organ transplantation.Although there are many studies in immune tolerance after transplantation,most of them are in the experimental stage,with seldom programs applied in patients.Compared to regulatory T cells,donor specific regulatory T cells are less investigated in immune tolerance,because of lower percentages and difficult preparing methods.This paper will summarize the hotspots of researches related to donor-specific regulatory T cells in recent years from the generality of regulatory T cells,suppressive function of donor specific regulatory T cells,culture technique in vitro and thymus transplantation,in order to provide new ideas to clinical research.
作者 王凯 高伟 WANG Kai;GAO Wei(Transplant Department,Tianjin First Center Hospital,Key Laboratory of Organ Transplantation of Tianjin,Tianjin Clinical Research Center for Organ Transplantation,Tianjin 300192,China)
出处 《天津医药》 CAS 北大核心 2019年第11期1196-1200,共5页 Tianjin Medical Journal
基金 天津市自然科学基金(17JCYBJC27500) 中国器官移植发展基金会“菁英计划”(2019JYJH03)
关键词 调节性T细胞 肝移植 免疫耐受 供体 regulatory T cell organ transplantation immune tolerance donor
  • 相关文献

参考文献3

二级参考文献17

  • 1Pilat N, Baranyi U, Klaus C, et al. Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning [J]. Am J Transplant, 2010, 10(4) : 751-762.
  • 2Fujiki M, Esquivel CO, Martinez OM, et al. Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CIM + CD25 + FoxP3 + T regulatory ceils [ J ]. Liver Transpl, 2010, 16(2) : 147-154.
  • 3Haxhinasto S, Mathis D, Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4 + FoxP3 + cells [ J ]. J Exp Med, 2008, 205(3) : 565-574.
  • 4Delgoffe GM, Kole TP, Zheng Y, et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment [J]. Immunity, 2009, 30(6): 832-844.
  • 5Demirkiran A, Hendrikx TK, Baan CC, et al. Impact of immunosuppressive drugs on CIM + CD25 +FoxP3 + regulatory T cells: does in vitro evidence translate to the clinical setting? [ J]. Transplantation, 2008, 85 (6) : 783-789.
  • 6Lu L, Qian XF, Rao JH, et al. Rapamycin promotes the expansion of CIM+ FoxP3+ regulatory T cells after liver transplantation [ J ]. Transplant Proc, 2010, 42 ( 5 ) : 1755-1757.
  • 7Xu G, Wang L, Chen W, et al. Rapamycin and tacrolimus differentially modulate acute graft-versus-host disease in rats after liver transplantation [ J]. Liver Transpl, 2010, 16 (3) : 357- 363.
  • 8Chu Z, Zhang J, Zhao Y, et al. Influence of immunosuppressive drugs on the development of CIM + CD25hlsh FoxP3 + T cells in liver transplant recipients [ J ]. Transplant Proc, 2010,42 ( 7 ) : 2599-2601.
  • 9Kim SH, Oh EJ, Ghee JY, et al. Clinical significance of monitoring circulating CIM + CD25 + regulatory T cells in kidney transplantation during the early posttransplant period [ J ]. J Korean Med Sci, 2009,24( Suppl 1 ) : S135-142.
  • 10Wang Z, Shi B, Jin H, et al. Low-dose of tacrolimus favors the induction of functional CD4 + CD25 + FoxP3 + regulatory T cells in solid-organ transplantation [ J ]. Int Immunopharmacol, 2009, 9 (5) : 564-569.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部